Patient Power®
Get Email Alerts!
Health Topics
Chronic Lymphocytic Leukemia (CLL) Health Center
Health Center Home Audio Programs Videos Conference Coverage
  • ASH 2011
    • Partner Spotlight
    Search by Keyword:
    Search by Health Topic:
    View all Health Topics >
    Spring Survey 2012
    1/25/12

    Driving CLL Away with CARs: Update on Chimeric Antigen Receptor Research from ASH 2011

    Chimeric Antigen Receptors (CARs) have been making news in CLL research this past year.  In this video from ASH 2011, Dr. John Gribben, from the Barts Cancer Institute in London, explains how training a patient's immune system to recognize the CLL cells it missed the first time may lead to breakthrough, personalized treatment in the near future.  While Dr. Gribben realizes many patients are very excited about this new treatment approach, he stresses that it is still in its infancy, and needs further research.

    Get Email Updates:

    Get updated automatically when new content about Chronic Lymphocytic Leukemia has been posted.
    Privacy Policy
    Chronic Lymphocytic Leukemia

    Experts & Guests

    John Gribben, M.D., DScn, FRCPathn, FRCP FMed John Gribben, M.D., DScn, FRCPathn, FRCP FMed
    Professor and Consultant Medical Oncologist, Barts and The London School of Medicine and Dentistry, Queen Mary, University of London
    Dr. Gribben specializes in hematology/oncology; lymphoma; chronic lymphocytic leukemia; and bone marrow transplantation. He received his medical training from the University of Glasgow, University College London and Harvard Medical School. He is a member of the CLL Research Consortium and has more than 200 peer reviewed articles in medical journals.  more >

    Transcript

    1. Driving CLL Away with CARs

    Related Videos

    Dr. Steven Rosen, Director of the Lurie Cancer Center in Chicago, shares his perspective on the latest news from the American Society of Hematology's 2011 annual meeting, focused around major advances in Chronic Lymphocytic Leukemia (CLL)...

    Watch Now
    Dr. Michael Keating, President of the CLL Global Research Foundation, gives an overview of treatment and research from the past year and looks forward to 2012

    Watch Now
    Dr. Susan O'Brien talks about the promise of therapy that may eventually replace chemotherapy treatment for some CLL patients

    Watch Now